Successful vaccination for Lyme disease: a novel mechanism. Expert opinion on investigational drugs Thanassi, W. T., Schoen, R. T. 1999; 8 (1): 29-35


Two vaccines are on the horizon for the prevention of Lyme disease, the most common vector-borne illness in the US and Europe. This review describes the pathogenesis and clinical illness of Lyme disease, as well as the sequence of events that led to the development of these novel vaccines. The results of the most recent Phase III human trials are reported.

View details for DOI 10.1517/13543784.8.1.29

View details for PubMedID 15992056